User:Mr. Ibrahem/Estramustine phosphate

Estramustine phosphate (EMP), sold under the brand names Emcyt among others, is a medication used to treat prostate cancer. Specifically it is used when the disease is hormone refractory. It is taken by mouth three to four times per day.

Common side effects include diarrhea, heart failure, low red blood cells, breast enlargement, liver problems, blood clots, and nausea. Other side effects may include sexual dysfunction, high blood pressure, and angioedema. Use in pregnancy may harm the baby. It is made by joining an estradiol with a nitrogen mustard.

Estramustine phosphate was introduced for medical use in the early 1970s. It is available in the United States, Canada, the United Kingdom, and other European countries, among others. In the United Kingdom 100 tablets of 140 mg costs the NHS about £170 as of 2021. This amount in the United States costs about 1,600 USD.